comparemela.com
Home
Live Updates
An EpiPen For Heart Attacks? Idorsia Launches Phase III Study Of Selatogrel : comparemela.com
An EpiPen For Heart Attacks? Idorsia Launches Phase III Study Of Selatogrel
Jean-Paul Clozel, whose firm Actelion was bought by Johnson & Johnson for $30bn, is back with his new company and a new approach to help save the lives of heart attack patients.
Related Keywords
United States ,
Switzerland ,
Oklahoma ,
Americans ,
Swiss ,
Jean Paul Clozel ,
Sebastien Roux ,
Bill Gates ,
Antares Pharma ,
Drug Administration ,
Credit Suisse ,
Us Centers For Disease ,
Astrazeneca ,
Selatogrel Outcome ,
Special Protocol Assessment ,
Paul Clozel ,
Disease Control ,
,
comparemela.com © 2020. All Rights Reserved.